Joseph C. Scodari - 06 Jan 2025 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Joseph C. Scodari
Issuer symbol
ACXP
Transactions as of
06 Jan 2025
Transactions value $
$25,000
Form type
4
Filing time
08 Jan 2025, 16:32:30 UTC
Previous filing
18 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Purchase $25,000 +24,631 +800% $1.02 27,708 06 Jan 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Purchase $0 +24,631 $0 24,631 06 Jan 2025 Common Stock 24,631 $0.9 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
F2 Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.